ADMA Biologics Inc header image

ADMA Biologics Inc

ADMA

Equity

ISIN null / Valor 20794750

NASDAQ (2026-10-29)
USD 11.75+4.17%

ADMA Biologics Inc
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

ADMA Biologics Inc is a biopharmaceutical company focused on the development, manufacturing, and commercialization of human plasma-derived immunoglobulins. The company specializes in the collection of human plasma, which is a critical component in the creation of therapies aimed at treating and preventing various diseases. Through its ADMA BioCenters, the company operates a network of FDA-regulated facilities dedicated to the safe and efficient collection of high-quality human plasma. This plasma is then utilized in the production of ADMA's proprietary immunoglobulin products, which are designed to address unmet medical needs in immune-deficient patients and other populations vulnerable to infectious diseases. By controlling the process from plasma collection to product manufacturing, ADMA Biologics ensures a consistent and reliable supply of specialized therapeutic products.

Summarized from source with an LLMView SourceSector: Technology

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-24.3%1Y
255%3Y
811%5Y

Performance

55.4%1Y
56.5%3Y
58.3%5Y

Volatility

Market cap

2632 M

Market cap (USD)

Daily traded volume (Shares)

2,744,752

Daily traded volume (Shares)

1 day high/low

17.53 / 16.98

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Salesforce Inc
Salesforce Inc Salesforce Inc Valor: 1755645
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.34%USD 231.69
Veracyte Inc
Veracyte Inc Veracyte Inc Valor: 22423969
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.70%USD 52.17
LG Electronics Inc. Sponsored GDR Pfd 144A
LG Electronics Inc. Sponsored GDR Pfd 144A LG Electronics Inc. Sponsored GDR Pfd 144A Valor: 1405127
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-5.92%GBP 15.70
ProFrac Holding Corp
ProFrac Holding Corp ProFrac Holding Corp Valor: 115040472
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.81%USD 4.85
Hewlett Packard Enterprise Co
Hewlett Packard Enterprise Co Hewlett Packard Enterprise Co Valor: 29968909
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.42%USD 58.87
Uber Technologies Inc
Uber Technologies Inc Uber Technologies Inc Valor: 47459333
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.49%USD 65.42
Bio-Techne Corp
Bio-Techne Corp Bio-Techne Corp Valor: 25995847
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.03%USD 72.71
United Therapeutics Corp
United Therapeutics Corp United Therapeutics Corp Valor: 848383
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.20%USD 593.54
Paylocity Holding Corp
Paylocity Holding Corp Paylocity Holding Corp Valor: 23606709
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.06%USD 168.40
Okta Inc
Okta Inc Okta Inc Valor: 36082513
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.36%USD 221.86